[1]
Levy JH, Szlam F, Wolberg AS, Winkler A. Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing. Clinics in laboratory medicine. 2014 Sep:34(3):453-77. doi: 10.1016/j.cll.2014.06.005. Epub 2014 Jul 28
[PubMed PMID: 25168937]
[2]
Triplett DA. Coagulation and bleeding disorders: review and update. Clinical chemistry. 2000 Aug:46(8 Pt 2):1260-9
[PubMed PMID: 10926920]
[3]
van den Besselaar AM, Chantarangkul V, Tripodi A. Thromboplastin standards. Biologicals : journal of the International Association of Biological Standardization. 2010 Jul:38(4):430-6. doi: 10.1016/j.biologicals.2010.02.012. Epub 2010 Mar 24
[PubMed PMID: 20338779]
[4]
Barcellona D, Fenu L, Marongiu F. Point-of-care testing INR: an overview. Clinical chemistry and laboratory medicine. 2017 May 1:55(6):800-805. doi: 10.1515/cclm-2016-0381. Epub
[PubMed PMID: 27754958]
Level 3 (low-level) evidence
[5]
Stein P, Kaserer A, Spahn GH, Spahn DR. Point-of-Care Coagulation Monitoring in Trauma Patients. Seminars in thrombosis and hemostasis. 2017 Jun:43(4):367-374. doi: 10.1055/s-0037-1598062. Epub 2017 Mar 15
[PubMed PMID: 28297730]
[6]
Ebner M, Birschmann I, Peter A, Spencer C, Härtig F, Kuhn J, Blumenstock G, Zuern CS, Ziemann U, Poli S. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants. Critical care (London, England). 2017 Feb 15:21(1):32. doi: 10.1186/s13054-017-1619-z. Epub 2017 Feb 15
[PubMed PMID: 28196509]
[7]
Bolliger D, Tanaka KA. Point-of-Care Coagulation Testing in Cardiac Surgery. Seminars in thrombosis and hemostasis. 2017 Jun:43(4):386-396. doi: 10.1055/s-0037-1599153. Epub 2017 Mar 30
[PubMed PMID: 28359133]
[8]
Magnette A, Chatelain M, Chatelain B, Ten Cate H, Mullier F. Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories. Thrombosis journal. 2016:14():49. doi: 10.1186/s12959-016-0123-z. Epub 2016 Dec 12
[PubMed PMID: 27999475]
[9]
Hinds PS, Quargnenti A, Gattuso J, Kumar Srivastova D, Tong X, Penn L, West N, Cathey P, Hawkins D, Wilimas J, Starr M, Head D. Comparing the results of coagulation tests on blood drawn by venipuncture and through heparinized tunneled venous access devices in pediatric patients with cancer. Oncology nursing forum. 2002 Apr:29(3):E26-34
[PubMed PMID: 11979291]
[10]
Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clinic proceedings. 2007 Jul:82(7):864-73
[PubMed PMID: 17605969]
[11]
Winter WE, Flax SD, Harris NS. Coagulation Testing in the Core Laboratory. Laboratory medicine. 2017 Nov 8:48(4):295-313. doi: 10.1093/labmed/lmx050. Epub
[PubMed PMID: 29126301]
[12]
Lippi G, Plebani M, Favaloro EJ. Interference in coagulation testing: focus on spurious hemolysis, icterus, and lipemia. Seminars in thrombosis and hemostasis. 2013 Apr:39(3):258-66. doi: 10.1055/s-0032-1328972. Epub 2012 Dec 10
[PubMed PMID: 23229354]
[13]
Opartkiattikul N. Standardization of coagulation tests. The Southeast Asian journal of tropical medicine and public health. 1999:30 Suppl 3():79-85
[PubMed PMID: 10926265]
[14]
Kagawa K. [Prothrombin time and its standardization]. Rinsho byori. The Japanese journal of clinical pathology. 2002 Aug:50(8):779-85
[PubMed PMID: 12373814]
[15]
Scherer-Burić RA, Lesser-Wetzold K, Nagel D, Weigand M, Spannagl M, Teupser D, Bruegel M. Performance testing of four automated coagulation analyzers in a university hospital setting with focus on global coagulation assays. International journal of laboratory hematology. 2022 Jun:44(3):643-653. doi: 10.1111/ijlh.13814. Epub 2022 Feb 18
[PubMed PMID: 35179298]
[16]
Lim HY, Donnan G, Nandurkar H, Ho P. Global coagulation assays in hypercoagulable states. Journal of thrombosis and thrombolysis. 2022 Jul:54(1):132-144. doi: 10.1007/s11239-021-02621-1. Epub 2022 Jan 8
[PubMed PMID: 34997471]
[17]
Huber AR, Méndez A, Brunner-Agten S. Automation in haemostasis. Hamostaseologie. 2013:33(4):295-8. doi: 10.5482/HAMO-12-05-0002. Epub 2013 Mar 5
[PubMed PMID: 23460141]
[18]
Aggarwal S, Nayak DM, Manohar C. Discrepancy in optical & mechanical method in coagulation tests in a turbid sample. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion. 2014 Sep:30(Suppl 1):402-4. doi: 10.1007/s12288-014-0438-5. Epub 2014 Aug 17
[PubMed PMID: 25332631]
[19]
Tekkesin N, Kılınc C. Optical and mechanical clot detection methodologies: a comparison study for routine coagulation testing. Journal of clinical laboratory analysis. 2012 May:26(3):125-9. doi: 10.1002/jcla.21497. Epub
[PubMed PMID: 22628225]
[20]
Bai B, Christie DJ, Gorman RT, Wu JR. Comparison of optical and mechanical clot detection for routine coagulation testing in a large volume clinical laboratory. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 2008 Sep:19(6):569-76. doi: 10.1097/MBC.0b013e3283070872. Epub
[PubMed PMID: 18685440]
[21]
Walenga JM, Fareed J. Automation and quality control in the coagulation laboratory. Clinics in laboratory medicine. 1994 Dec:14(4):709-28
[PubMed PMID: 7874868]
Level 2 (mid-level) evidence
[22]
Hertzberg MS, Mammen J, McCraw A, Nair SC, Srivastava A. Achieving and maintaining quality in the laboratory. Haemophilia : the official journal of the World Federation of Hemophilia. 2006 Jul:12 Suppl 3():61-7
[PubMed PMID: 16683998]
Level 2 (mid-level) evidence
[23]
Ruiz-de-Chávez-Ochoa AA, Núñez-Pérez E, Muñoz-Muñoz B, Majluf-Cruz A. [The quality control in the coagulation laboratory]. Revista medica del Instituto Mexicano del Seguro Social. 2008 May-Jun:46(3):339-48
[PubMed PMID: 19133213]
Level 2 (mid-level) evidence
[24]
McFarlane A, Aslan B, Raby A, Moffat KA, Selby R, Padmore R. Internal Quality Control Practices in Coagulation Laboratories: recommendations based on a patterns-of-practice survey. International journal of laboratory hematology. 2015 Dec:37(6):729-38. doi: 10.1111/ijlh.12397. Epub 2015 Jun 24
[PubMed PMID: 26108698]
Level 2 (mid-level) evidence
[25]
Lu Y, Yang F, Wen D, Shi K, Gu Z, Lu Q, Wang X, Dong D. Assessment of patient based real-time quality control on comparative assays for common clinical analytes. Journal of clinical laboratory analysis. 2022 Sep:36(9):e24651. doi: 10.1002/jcla.24651. Epub 2022 Aug 10
[PubMed PMID: 35949026]
Level 2 (mid-level) evidence
[26]
Loh TP, Bietenbeck A, Cervinski MA, van Rossum HH, Katayev A, Badrick T, International Federation of Clinical Chemistry and Laboratory Medicine Committee on Analytical Quality. Recommendation for performance verification of patient-based real-time quality control. Clinical chemistry and laboratory medicine. 2020 Jul 28:58(8):1205-1213. doi: 10.1515/cclm-2019-1024. Epub
[PubMed PMID: 32049646]
Level 2 (mid-level) evidence
[27]
Kinns H, Pitkin S, Housley D, Freedman DB. Internal quality control: best practice. Journal of clinical pathology. 2013 Dec:66(12):1027-32. doi: 10.1136/jclinpath-2013-201661. Epub 2013 Sep 26
[PubMed PMID: 24072731]
Level 2 (mid-level) evidence
[28]
Westgard JO. Internal quality control: planning and implementation strategies. Annals of clinical biochemistry. 2003 Nov:40(Pt 6):593-611
[PubMed PMID: 14629798]
Level 2 (mid-level) evidence
[29]
Mrazek C, Lippi G, Keppel MH, Felder TK, Oberkofler H, Haschke-Becher E, Cadamuro J. Errors within the total laboratory testing process, from test selection to medical decision-making - A review of causes, consequences, surveillance and solutions. Biochemia medica. 2020 Jun 15:30(2):020502. doi: 10.11613/BM.2020.020502. Epub
[PubMed PMID: 32550813]
[30]
Ricós C, García-Victoria M, de la Fuente B. Quality indicators and specifications for the extra-analytical phases in clinical laboratory management. Clinical chemistry and laboratory medicine. 2004:42(6):578-82
[PubMed PMID: 15259371]
Level 2 (mid-level) evidence
[31]
Badrick T. Integrating quality control and external quality assurance. Clinical biochemistry. 2021 Sep:95():15-27. doi: 10.1016/j.clinbiochem.2021.05.003. Epub 2021 May 7
[PubMed PMID: 33965412]
Level 2 (mid-level) evidence
[32]
Smock KJ, Moser KA. What have we learned from coagulation laboratory participation in external quality programs? International journal of laboratory hematology. 2019 May:41 Suppl 1():49-55. doi: 10.1111/ijlh.12998. Epub
[PubMed PMID: 31069983]
Level 2 (mid-level) evidence
[33]
De la Salle B. Survey material choices in haematology EQA: a confounding factor in automated counting performance assessment. Biochemia medica. 2017 Feb 15:27(1):63-72. doi: 10.11613/BM.2017.008. Epub
[PubMed PMID: 28392727]
Level 3 (low-level) evidence
[34]
Della Valle P, Crippa L, Garlando AM, Pattarini E, Safa O, Viganò D'Angelo S, D'Angelo A. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Haematologica. 1999 Dec:84(12):1065-74
[PubMed PMID: 10586206]
[35]
Kremers RMW, Zuily S, Kelchtermans H, Peters TC, Bloemen S, Regnault V, Hemker HC, de Groot PG, Wahl D, de Laat B. Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin. Blood advances. 2018 Jun 12:2(11):1315-1324. doi: 10.1182/bloodadvances.2018018036. Epub
[PubMed PMID: 29895622]
Level 3 (low-level) evidence
[36]
Hanslik T, Prinseau J. The use of vitamin K in patients on anticoagulant therapy: a practical guide. American journal of cardiovascular drugs : drugs, devices, and other interventions. 2004:4(1):43-55
[PubMed PMID: 14967065]
[37]
Martinuzzo M, Barrera L, Rodriguez M, D'Adamo MA, López MS, Otaso JC. Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients? International journal of laboratory hematology. 2015 Dec:37(6):853-60. doi: 10.1111/ijlh.12424. Epub 2015 Sep 4
[PubMed PMID: 26338156]
[38]
Gosselin RC, Marlar RA. Preanalytical Variables in Coagulation Testing: Setting the Stage for Accurate Results. Seminars in thrombosis and hemostasis. 2019 Jul:45(5):433-448. doi: 10.1055/s-0039-1692700. Epub 2019 Jul 10
[PubMed PMID: 31291676]
[39]
Lippi G, Favaloro EJ. Preanalytical Issues in Hemostasis and Thrombosis Testing. Methods in molecular biology (Clifton, N.J.). 2017:1646():29-42. doi: 10.1007/978-1-4939-7196-1_2. Epub
[PubMed PMID: 28804816]
[40]
Adcock Funk DM, Lippi G, Favaloro EJ. Quality standards for sample processing, transportation, and storage in hemostasis testing. Seminars in thrombosis and hemostasis. 2012 Sep:38(6):576-85. doi: 10.1055/s-0032-1319768. Epub 2012 Jun 16
[PubMed PMID: 22706973]
Level 2 (mid-level) evidence
[41]
Haripersadh R, Pillay D, Rapiti N. Impact of rapid centrifugation on routine coagulation assays in South Africa. African journal of laboratory medicine. 2022:11(1):1901. doi: 10.4102/ajlm.v11i1.1901. Epub 2022 Nov 28
[PubMed PMID: 36483324]
[42]
Gosselin RC, Honeychurch K, Kang HJ, Dwyre DM. Effect of Multiple Freeze-Thaw Cycles on Coagulation Testing. Seminars in thrombosis and hemostasis. 2020 Jun:46(4):515-520. doi: 10.1055/s-0040-1709474. Epub 2020 May 21
[PubMed PMID: 32438422]
[43]
Hellenbart EL, Faulkenberg KD, Finks SW. Evaluation of bleeding in patients receiving direct oral anticoagulants. Vascular health and risk management. 2017:13():325-342. doi: 10.2147/VHRM.S121661. Epub 2017 Aug 23
[PubMed PMID: 28860793]
[44]
Kim JA, Kim JE, Song SH, Kim HK. Influence of blood lipids on global coagulation test results. Annals of laboratory medicine. 2015 Jan:35(1):15-21. doi: 10.3343/alm.2015.35.1.15. Epub 2014 Dec 8
[PubMed PMID: 25553275]